Development and characterization of ketorolac tromethamine osmotic pump tablets

被引:9
|
作者
Ali, A. A. [1 ]
Sayed, O. M. [1 ]
机构
[1] Beni Suef Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Bani Sweif, Egypt
关键词
Ketorolac tromethamine; Cellulose acetate; Osmotic pump tablets; Semi-permeable membrane; Zero-order release; ORAL-DRUG DELIVERY; INDENTED CORE TABLET; FORMULATION VARIABLES; RELEASE; SYSTEM; HYDROCHLORIDE; PLASTICIZERS; TECHNOLOGY; MEMBRANE; DESIGN;
D O I
10.1016/S1773-2247(13)50041-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to prepare and evaluate elementary osmotic pump tablets (OPT) of ketorolac tromethamine (KT). Because of its high potency, short half-life and excellent water solubility it would appear to be the drug of choice for these formulations. Twenty OPT formulae were prepared and subjected to release-rate study and the release data were analyzed to determine the drug release order. Compatibility study between KT and the used excipients was carried out also scanning electron microscopy in order to elucidate the microporous nature of the tablet surfaces. The effects of an increase in weight, agitation intensity, pH and type of coating polymer on drug release from the optimal formulation (OPT-19) were studied. It was found that the optimal OPT formula was able to deliver KT at a zero-order for up to 12 h independent of both release media and agitation rates: the effect of type of coating polymer was not significant.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 50 条
  • [21] EFFECTS OF KETOROLAC TROMETHAMINE ON HEMOSTASIS
    GREER, IA
    [J]. PHARMACOTHERAPY, 1990, 10 (06): : S71 - S76
  • [22] HPTLC determination of ketorolac tromethamine
    Devarajan, PV
    Gore, SP
    Chavan, SV
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (04) : 679 - 683
  • [23] LIGHT DEGRADATION OF KETOROLAC TROMETHAMINE
    GU, L
    CHIANG, HS
    JOHNSON, D
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 41 (1-2) : 105 - 113
  • [24] Development of a nasal formulation containing ketorolac tromethamine and metoclopramide hydrochloride
    Sheth, P
    Zia, H
    Needham, T
    [J]. STP PHARMA SCIENCES, 2002, 12 (01): : 39 - 44
  • [25] Preparation and characterization of silymarin synchronized-release microporous osmotic pump tablets
    Zeng, Qi-ping
    Liu, Zhi-hong
    Huang, Ai-wen
    Zhang, Jing
    Song, Hong-tao
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 519 - +
  • [26] COMMENTS ON KETOROLAC TROMETHAMINE FOR INJECTION
    STARNES, CC
    HAGLER, L
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (05): : 912 - 912
  • [27] Ketorolac tromethamine in cancer pain
    Yalcin, S
    Gullu, I
    Tekuzman, G
    Savas, C
    [J]. ACTA ONCOLOGICA, 1997, 36 (02) : 231 - 232
  • [28] Formulation and Development of Proniosomal Gel for Transdermal Delivery of Ketorolac Tromethamine
    Farooqui, Nadeem
    Kar, Mousumi
    Singh, Ravindra Pal
    [J]. ASIAN JOURNAL OF PHARMACEUTICS, 2016, 10 (03) : S394 - S400
  • [29] Development and In Vitro/In Vivo Evaluation of Etodolac Controlled Porosity Osmotic Pump Tablets
    Abd-Elbary, Ahmed
    Tadros, Mina Ibrahim
    Alaa-Eldin, Ahmed Adel
    [J]. AAPS PHARMSCITECH, 2011, 12 (02): : 485 - 495
  • [30] Development and In Vitro/In Vivo Evaluation of Etodolac Controlled Porosity Osmotic Pump Tablets
    Ahmed Abd-Elbary
    Mina Ibrahim Tadros
    Ahmed Adel Alaa-Eldin
    [J]. AAPS PharmSciTech, 2011, 12 : 485 - 495